دورية أكاديمية
Association of Single-Nucleotide Polymorphisms in the VDR Gene with Tuberculosis and Infection of Beijing Genotype Mycobacterium tuberculosis .
العنوان: | Association of Single-Nucleotide Polymorphisms in the VDR Gene with Tuberculosis and Infection of Beijing Genotype Mycobacterium tuberculosis . |
---|---|
المؤلفون: | Yu J; School of Public Health, University of South China, Hengyang, 421001, People's Republic of China.; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Liu M; School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China., Mijiti X; The Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China., Liu H; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Wang Q; The Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China., Yin C; School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China., Anwaierjiang A; College of Xinjiang Uyghur Medicine, Hetian, 848000, People's Republic of China., Xu M; The Eighth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830049, People's Republic of China., Li M; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Deng L; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China.; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China., Xiao H; School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang, 830011, People's Republic of China., Zhao X; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Wan K; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Li G; State Key Laboratory for Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, People's Republic of China., Yuan X; School of Public Health, University of South China, Hengyang, 421001, People's Republic of China. |
المصدر: | Infection and drug resistance [Infect Drug Resist] 2023 May 22; Vol. 16, pp. 3157-3169. Date of Electronic Publication: 2023 May 22 (Print Publication: 2023). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101550216 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6973 (Print) Linking ISSN: 11786973 NLM ISO Abbreviation: Infect Drug Resist Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Auckland, N.Z. : Dove Medical Press, 2008- |
مستخلص: | Background: The aim of the present study was to investigate the association between vitamin D receptor ( VDR ) gene polymorphism and tuberculosis susceptibility, as well as the potential interaction of host genetic factors with the heterogeneity of Mycobacterium tuberculosis in the population from Xinjiang, China. Methods: From January 2019 to January 2020, we enrolled 221 tuberculosis patients as the case group and 363 staff with no clinical symptoms as the control group from four designated tuberculosis hospitals in southern Xinjiang, China. The polymorphisms of Fok I, Taq I, Apa I, Bsm I, rs3847987 and rs739837 in the VDR were detected by sequencing. M. tuberculosis isolates were collected from the case group and identified as Beijing or non-Beijing lineage by multiplex PCR. Propensity score (PS), univariate analysis and multivariable logistic regression models were used to perform the analysis. Results: Our results showed that the allele and genotype frequencies of Fok I, Taq I, Apa I, Bsm I, rs3847987 and rs739837 in VDR were not correlated with tuberculosis susceptibility or lineages of M. tuberculosis . Two out of six loci of the VDR gene formed one haplotype block, and none of the haplotypes was found to correlate with tuberculosis susceptibility or lineages of M. tuberculosis infected. Conclusion: Polymorphisms in the VDR gene may not indicate susceptibility to tuberculosis. There was also no evidence on the interaction between the VDR gene of host and the lineages of M. tuberculosis in the population from Xinjiang, China. Further studies are nonetheless required to prove our conclusions. Competing Interests: We have no conflicts of interest to declare. (© 2023 Yu et al.) |
References: | Stat Med. 2005 May 15;24(9):1291-306. (PMID: 15568190) Infect Genet Evol. 2011 Aug;11(6):1456-61. (PMID: 21645645) J Infect. 2019 Dec;79(6):572-581. (PMID: 31585190) Sci China Life Sci. 2018 Jun;61(6):651-659. (PMID: 29790059) Lancet Infect Dis. 2018 Mar;18(3):e64-e75. (PMID: 29111156) Front Immunol. 2020 Jul 21;11:1553. (PMID: 32849525) Bioinformatics. 2005 Jan 15;21(2):263-5. (PMID: 15297300) Medicine (Baltimore). 2016 Apr;95(17):e3418. (PMID: 27124026) Mol Biol Rep. 2020 Mar;47(3):1659-1666. (PMID: 31933264) Genomics. 2021 Jul;113(4):1802-1815. (PMID: 33862184) Nat Genet. 2013 Oct;45(10):1176-82. (PMID: 23995134) Microb Pathog. 2019 May;130:59-64. (PMID: 30822458) PLoS One. 2012;7(3):e32976. (PMID: 22412962) J Clin Transl Endocrinol. 2014 Dec 1;1(4):151-160. (PMID: 25599020) PLoS Pathog. 2008 Mar 28;4(3):e1000034. (PMID: 18369480) Infect Dis (Lond). 2016 Feb;48(2):108-15. (PMID: 26414438) Am Rev Respir Dis. 1978 Apr;117(4):621-4. (PMID: 565607) Sci Rep. 2017 Apr 21;7(1):1068. (PMID: 28432321) Int J Tuberc Lung Dis. 2001 Aug;5(8):754-62. (PMID: 11495267) Am J Respir Crit Care Med. 2004 Mar 1;169(5):610-4. (PMID: 14701710) PLoS One. 2012;7(8):e41618. (PMID: 22879892) Hum Mol Genet. 2021 Apr 26;30(R1):R146-R153. (PMID: 33258469) Biomed Res Int. 2013;2013:484535. (PMID: 24024195) PLoS One. 2011;6(12):e29190. (PMID: 22220207) Immunol Invest. 2022 Jan;51(1):73-87. (PMID: 32847384) PLoS Genet. 2020 Apr 30;16(4):e1008728. (PMID: 32352966) Immunology. 1986 Jan;57(1):159-63. (PMID: 3002968) Emerg Infect Dis. 2002 Aug;8(8):843-9. (PMID: 12141971) Can J Physiol Pharmacol. 2015 May;93(5):377-84. (PMID: 25744368) Int J Infect Dis. 2020 Sep;98:447-453. (PMID: 32619758) Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jan 25;:. (PMID: 36707289) J Infect Dis. 2009 Dec 1;200(11):1671-4. (PMID: 19863441) Antibiotics (Basel). 2020 Jun 08;9(6):. (PMID: 32521634) BMC Pulm Med. 2017 Jun 5;17(1):89. (PMID: 28583097) Innate Immun. 2019 Jul;25(5):305-313. (PMID: 30987490) Nat Rev Immunol. 2013 Apr;13(4):280-93. (PMID: 23470320) PLoS One. 2011;6(6):e20908. (PMID: 21695215) Clin Infect Dis. 2019 Aug 16;69(5):813-819. (PMID: 30481273) J Hum Genet. 2017 Dec;62(12):1015-1022. (PMID: 28878339) Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2869-73. (PMID: 16477032) |
فهرسة مساهمة: | Keywords: Beijing lineage; Mycobacterium tuberculosis; VDR; polymorphism; tuberculosis; vitamin D receptor |
تواريخ الأحداث: | Date Created: 20230526 Latest Revision: 20230528 |
رمز التحديث: | 20230528 |
مُعرف محوري في PubMed: | PMC10208660 |
DOI: | 10.2147/IDR.S407595 |
PMID: | 37235072 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1178-6973 |
---|---|
DOI: | 10.2147/IDR.S407595 |